Carlos R. Hamilton, Jr., MD, FACE, has practiced clinical endocrinology and internal medicine, and he is the executive vice president of the University of Texas Health Science Center at Houston and a professor of internal medicine at the UT Houston Medical School. After graduating from Baylor College of Medicine, he completed his internship and residency at the Johns Hopkins Hospital, an endocrine fellowship at the Massachusetts General Hospital, and was chief resident in medicine at Hopkins. He was on the full-time faculty at Hopkins before serving two years as an endocrinologist at the Wilford Hall USAF Medical Center in San Antonio. He was in private practice for 26 years and was a clinical professor of medicine at Baylor College of Medicine before assuming his present position.

Dr. Hamilton has been active in medical organizations primarily as an advocate for medical practice and patient's rights. He has been a member of the AACE board of directors and served as chair of the AACE legislative and regulatory committee. He has also served as president of the Texas Society of Internal Medicine, the Harris County Medical Society and as chair of the Texas Medical Association Political Action Committee. He has served as a trustee of the American Society of Internal Medicine, as a member of the ACP-ASIM Health and Public Policy Committee and as a member of the AMA Federation Advisory Committee. He served as the 2004–2005 AACE president and as a trustee of the American College of Endocrinology. He is a past president on the AACE board of directors and president-elect of the American College of Endocrinology. He is a member of the practicing physicians advisory council to the US Secretary of Health and Human Services for issues related to the Center of Medicare and Medicaid Services. He also serves on the health, medicine and research committee of the World Anti-Doping Agency, which oversees the international prohibitions of the use of hormones and performance enhancing substances in athletic competition.

Joseph J. Torre, M.D., F.A.C.P., F.A.C.E., is Clinical Assistant Professor of Medicine for the State University of New York at Buffalo where he has been in the private practice of endocrine consultation with the Buffalo Medical Group, P.C. since 1991. He served as chairman of the task force that developed the AACE Medical Guidelines for the Diagnosis and Management of Hypertension and as section editor of the Hypertension module of the AACE/ACE Self Assessment Program (ASAP) for 2007-2008. A graduate of the Boston University School of Medicine, his endocrinology career stemmed from an interest in the etiology of atherogenesis and research in platelet sensitivity and vascular reactivity associated with hyperlipidemia and diabetes mellitus at St. Luke’s Hospital Medical Center in NYC, NY, and later at the M.I.T. Arteriosclerosis Center in Cambridge, MA. Dr. Torre sees the clinical endocrinologist as the quintessential diagnostician and preventive medicine specialist. He credits AACE with helping to bring endocrinology from an esoteric subspecialty to the forefront of the clinical practice of internal medicine.

Paul S. Jellinger, MD, MACE, is a Past President of the American Association of Clinical Endocrinologists (AACE) and a Past President of the American College of Endocrinology (ACE). He is a Professor of Medicine on the voluntary faculty at the University of Miami. In May 2004, he became a Master of the American College of Endocrinology (MACE).

After receiving his medical degree from Wayne State University School of Medicine, Dr. Jellinger completed a first-year medical residency at Beth Israel Hospital and a second-year residency at Mount Sinai Hospital in New York City. He subsequently was awarded an NIH fellowship in Endocrinology at Mount Sinai Hospital. Dr. Jellinger has served as Chief of the Section of Endocrinology at Memorial Regional Hospital in Hollywood, Florida. He is involved in many regional and national professional and scientific associations including The Endocrine Society and the American Diabetes Association and is Past President of The Florida Endocrine Society. Dr. Jellinger is board certified in internal medicine and endocrinology and metabolism. He has also conducted investigative research on over 50 subjects and is currently conducting research for several major pharmaceutical companies. Dr. Jellinger currently serves as Medical Editor of Clinical Endocrinology News.

Dr. Jellinger, a founding member, was elected President of the American Association of Clinical Endocrinologists, a 5500 physician member organization, in May 2000. He has been active on the AACE Board of Directors and has served as chairman of several committees including the Clinical Research Committee. Dr. Jellinger was also a member of the Task Forces that defined and published the first AACE Guidelines for the Management of Diabetes Mellitus the Evaluation and Treatment of Hyperthyroidism and Hypothyroidism and the Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome. He served as Chairman of the Task Force for the published AACE Guidelines on the Treatment of Lipid Disorders in the Prevention of Atherogenesis. He was a participant in both the 2001 and 2002 “ACE/AACE Consensus Conferences on Glycemic Control” and the “Insulin Resistance Syndrome” and was a co-chairman of the recent “ACE/AACE Diabetes Consensus Conference on Implementation of Glycemic Goals.” He is co-chairman of the Task Force that recently published the ACE/AACE Roadmap for the Treatment and Prevention of Type 2 Diabetes and was a Task Force member and contributing author to the recently published AACE Medical Guidelines for the Management of Diabetes Mellitus. Dr. Jellinger lectures frequently on topics related to diabetes mellitus and lipid disorders.

Vijay Nambi is an Assistant Professor in the section of Atherosclerosis and Vascular Medicine, Baylor College of Medicine and Center for Cardiovascular Prevention, the Methodist DeBakey Heart Center. He also serves as the program director of the Atherosclerosis and Vascular Medicine fellowship at Baylor College of Medicine. His research interests are specifically in lipids, biomarkers, risk stratification and imaging as related to coronary and peripheral arterial disease. He has published 20 original articles and 3 book chapters.